Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1010
Histopathology Services Market Introduction: Histopathology is a microscopic study of tissue anatomy for examination of abnormalities. Histopathology services are utilized for preliminary diagnosis of medical indications in clinical settings. It plays important role in clinical studies to determine the efficacy, pharmacology and toxicology of the medical interventions. Histopathology includes sample collection and processing on-site for tissues abnormality detection by comparing with fully functional tissues. It also used for evaluation of implanted medical devices to understand the structural functions of the implants. Implants include bone plates, artificial cartilages, hip & knee prosthesis, fusion polymers, stents and others. Rapidly changing healthcare environment requires continuous innovation in preliminary diagnosis of disease for better management of the disease. Histopathology plays important role in the preliminary examination of disease and requires high capital for the establishment. Due to increasing demand histopathology services in healthcare environment created potential opportunities for the market. Further, increasing government support to advance the smart technologies in preliminary diagnosis has led to robust development of histopathology services. Additionally, technology has played crucial in minimizing the complication of the manual process and advanced the existing histopathology technologies. Other factors like increasing public investments in advancing the histopathology services have fuelled the growth of the market. Histopathology services are evolving at a faster pace to improve the quality and efficiency of the diagnosis and created the opportunistic space for new players in the global histopathology services market North America & Europe Histopathology Services market has witnessed a high market share in the global market due to the high adoption of technological advancements. Further, changing healthcare environment in developed economies has boosted the growth of the histopathology services market. Developing economies like the Asia Pacific and Latin America has witnessed fast growth during the forecast period due to increasing importance of primary diagnosis and last patient population. Histopathology Services Market Key Players are CPS Clinical Pathology Services, SRL DIAGNOSTICS FZ-LLC, Medsol Diagnostic, Cure, Thumbay Labs, Healthchecks360, National Reference Laboratory, CPS Clinical Pathology Services, Metropolis, Pure Health LLC, Freiburg, Unilabs, Eurofins Biominis, Agiomix FZ LLC, Thermo Fisher Scientific, Hoffman-la-Roche Ltd, Leica Biosystems, Agilent Technologies Inc., Merck KGaA, Abbott Laboratories, Sakura Fintek, Oxford Cancer Biomarkers. Histopathology Services Market Segmentations: By Product and Services • Products o Instruments • Tissue processor equipment • Tissue embedding equipment • Slide strainers systems • Cover slipper systems • Microtome & cryostat • Microscopes • Others o Consumables. • Service o Surgical Specimen Examination o Biopsies • Bone Marrow Biopsy Tissue Examination • Breast Core Biopsy Tissue Examination • Skin Biopsy, Kidney Biopsy Tissue Examination • Liver Biopsy Tissue Examination o Bile Duct Brushing o Cytology o Others By Application • Clinical/Diagnostic • Research By End User • Hospital based laboratories • Laboratories • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global histopathology services on the basis of product and services, application, end user, and region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and overall market • To predict market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Histopathology is a microscopic study of tissue anatomy for examination of abnormalities. Histopathology services are utilized for preliminary diagnosis of medical indications in clinical settings. It plays important role in clinical studies to determine the efficacy, pharmacology and toxicology of the medical interventions. Histopathology includes sample collection and processing on-site for tissues abnormality detection by comparing with fully functional tissues. It also used for evaluation of implanted medical devices to understand the structural functions of the implants. Implants include bone plates, artificial cartilages, hip & knee prosthesis, fusion polymers, stents and others.
Rapidly changing healthcare environment requires continuous innovation in preliminary diagnosis of disease for better management of the disease. Histopathology plays important role in the preliminary examination of disease and requires high capital for the establishment. Due to increasing demand histopathology services in healthcare environment created potential opportunities for the market. Further, increasing government support to advance the smart technologies in preliminary diagnosis has led to robust development of histopathology services. Additionally, technology has played crucial in minimizing the complication of the manual process and advanced the existing histopathology technologies. Other factors like increasing public investments in advancing the histopathology services have fuelled the growth of the market. Histopathology services are evolving at a faster pace to improve the quality and efficiency of the diagnosis and created the opportunistic space for new players in the global histopathology services market
North America & Europe Histopathology Services market has witnessed a high market share in the global market due to the high adoption of technological advancements. Further, changing healthcare environment in developed economies has boosted the growth of the histopathology services market. Developing economies like the Asia Pacific and Latin America has witnessed fast growth during the forecast period due to increasing importance of primary diagnosis and last patient population.
Histopathology Services Market Key Players are CPS Clinical Pathology Services, SRL DIAGNOSTICS FZ-LLC, Medsol Diagnostic, Cure, Thumbay Labs, Healthchecks360, National Reference Laboratory, CPS Clinical Pathology Services, Metropolis, Pure Health LLC, Freiburg, Unilabs, Eurofins Biominis, Agiomix FZ LLC, Thermo Fisher Scientific, Hoffman-la-Roche Ltd, Leica Biosystems, Agilent Technologies Inc., Merck KGaA, Abbott Laboratories, Sakura Fintek, Oxford Cancer Biomarkers.
Histopathology Services Market Segmentations:
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape:
Objectives of the Study: • To provide with an exhaustive analysis on the global histopathology services on the basis of product and services, application, end user, and region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and overall market • To predict market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Histopathology Services Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Histopathology Services Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Histopathology Services Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Histopathology Services Market, By Product and Services Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Products 7.1.1. Instruments 7.1.1.1. Tissue processor equipment 7.1.1.2. Tissue embedding equipment 7.1.1.3. Slide strainers systems 7.1.1.4. Cover slipper systems 7.1.1.5. Microtome & cryostat 7.1.1.6. Microscopes 7.1.1.7. Others 7.1.2. Consumables. 7.2. Service 7.2.1. Surgical Specimen Examination 7.2.2. Biopsies 7.2.2.1. Bone Marrow Biopsy Tissue Examination 7.2.2.2. Breast Core Biopsy Tissue Examination 7.2.2.3. Skin Biopsy, Kidney Biopsy Tissue Examination 7.2.2.4. Liver Biopsy Tissue Examination 7.2.3. Bile Duct Brushing 7.2.4. Cytology 7.2.5. Others 8. Global Histopathology Services Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Clinical/Diagnostic 8.2. Research 9. Global Histopathology Services Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospital based laboratories 9.2. Laboratories 9.3. Others 10. North America Histopathology Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Histopathology Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Histopathology Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Histopathology Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. CPS Clinical Pathology Services 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. SRL DIAGNOSTICS FZ-LLC 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Medsol Diagnostic 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Cure 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Thumbay Labs 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Healthchecks360 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. National Reference Laboratory 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. CPS Clinical Pathology Services 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Metropolis 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Pure Health LLC 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Freiburg 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Unilabs 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Eurofins Biominis 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Agiomix FZ LLC 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Thermo Fisher Scientific 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Hoffman-la-Roche Ltd. 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Leica Biosystems 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18.Agilent Technologies Inc 16.18.1. Company Overview 16.18.2. Product Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 16.19. Merck KGaA 16.19.1. Company Overview 16.19.2. Product Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview 16.20. Abbott Laboratories 16.20.1. Company Overview 16.20.2. Product Portfolio 16.20.3. SWOT Analysis 16.20.4. Financial Overview 16.20.5. Strategic Overview 16.21. Sakura Fintek 16.21.1. Company Overview 16.21.2. Product Portfolio 16.21.3. SWOT Analysis 16.21.4. Financial Overview 16.21.5. Strategic Overview 16.22. Oxford Cancer Biomarkers 16.22.1. Company Overview 16.22.2. Product Portfolio 16.22.3. SWOT Analysis 16.22.4. Financial Overview 16.22.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Histopathology Services Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Histopathology Services Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Histopathology Services Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Histopathology Services Market, By Product and Services Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Products 7.1.1. Instruments 7.1.1.1. Tissue processor equipment 7.1.1.2. Tissue embedding equipment 7.1.1.3. Slide strainers systems 7.1.1.4. Cover slipper systems 7.1.1.5. Microtome & cryostat 7.1.1.6. Microscopes 7.1.1.7. Others 7.1.2. Consumables. 7.2. Service 7.2.1. Surgical Specimen Examination 7.2.2. Biopsies 7.2.2.1. Bone Marrow Biopsy Tissue Examination 7.2.2.2. Breast Core Biopsy Tissue Examination 7.2.2.3. Skin Biopsy, Kidney Biopsy Tissue Examination 7.2.2.4. Liver Biopsy Tissue Examination 7.2.3. Bile Duct Brushing 7.2.4. Cytology 7.2.5. Others
8. Global Histopathology Services Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Clinical/Diagnostic 8.2. Research
9. Global Histopathology Services Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospital based laboratories 9.2. Laboratories 9.3. Others
10. North America Histopathology Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Histopathology Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Histopathology Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Histopathology Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. CPS Clinical Pathology Services 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. SRL DIAGNOSTICS FZ-LLC 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Medsol Diagnostic 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Cure 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Thumbay Labs 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Healthchecks360 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. National Reference Laboratory 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. CPS Clinical Pathology Services 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Metropolis 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Pure Health LLC 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Freiburg 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Unilabs 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Eurofins Biominis 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Agiomix FZ LLC 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Thermo Fisher Scientific 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Hoffman-la-Roche Ltd. 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Leica Biosystems 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18.Agilent Technologies Inc 16.18.1. Company Overview 16.18.2. Product Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 16.19. Merck KGaA 16.19.1. Company Overview 16.19.2. Product Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview 16.20. Abbott Laboratories 16.20.1. Company Overview 16.20.2. Product Portfolio 16.20.3. SWOT Analysis 16.20.4. Financial Overview 16.20.5. Strategic Overview 16.21. Sakura Fintek 16.21.1. Company Overview 16.21.2. Product Portfolio 16.21.3. SWOT Analysis 16.21.4. Financial Overview 16.21.5. Strategic Overview 16.22. Oxford Cancer Biomarkers 16.22.1. Company Overview 16.22.2. Product Portfolio 16.22.3. SWOT Analysis 16.22.4. Financial Overview 16.22.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics